Tech Company Financing Transactions
VenoStent Funding Round
On 8/1/2023, VenoStent raised $16 million in Series A funding from Good Growth Capital, Alumni Ventures and Baylor Angel Network.
Transaction Overview
Company Name
Announced On
8/1/2023
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand their US Pivotal Trial and their manufacturing capabilities, aiming towards FDA Approval of their novel therapeutic medical device.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
1710 Linden Ave.
Nashville, TN 37212
USA
Nashville, TN 37212
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
VenoStent, Inc. is an early stage medical device and biomaterial platform company company developing a shape memory polymer wrap to help hemodialysis patients live longer, less painful, and more prosperous lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Boire
Chief Operating Officer
Geoff Lucks
Browse more venture capital transactions:
Prev: 8/1/2023: Traction venture capital transaction
Next: 8/1/2023: Tilebox venture capital transaction
Share this article
News on VC Transactions
We document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs